Literature DB >> 30211453

Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada.

Jade Boyd1,2, Alexandra B Collins1,3, Samara Mayer1, Lisa Maher4, Thomas Kerr1,2, Ryan McNeil1,2.   

Abstract

BACKGROUND AND AIMS: North America's overdose epidemic is increasingly driven by fentanyl and fentanyl-adulterated drugs. Supervised consumption sites, including low-threshold models (termed overdose prevention sites; OPS), are now being debated in the United States and implemented in Canada. Despite evidence that gendered and racialized violence shape access to harm reduction among women who use drugs (WWUD), this has not been examined in relation to OPS and amid the overdose epidemic. This study explores how overlapping epidemics of overdose and gendered and racialized violence in Vancouver's Downtown Eastside, one of North America's overdose epicenters, impacts how marginalized WWUD experience OPS.
DESIGN: Qualitative analysis using rapid ethnographic fieldwork. Data collection included 185 hours of naturalistic observation and in-depth interviews; data were analyzed thematically using NVivo.
SETTING: Vancouver, Canada. PARTICIPANTS: Thirty-five WWUD recruited from three OPS. MEASUREMENTS: Participants' experiences of OPS and the public health emergency.
FINDINGS: The rapid onset and severity of intoxication associated with the use of fentanyl-adulterated drugs in less regulated drug use settings not only amplified WWUD's vulnerability to overdose death but also violence. Participants characterized OPS as safer spaces to consume drugs in contrast to less regulated settings, and accommodation of assisted injections and injecting partnerships was critical to increasing OPS access among WWUD. Peer-administered injections disrupted gendered power relations to allow women increased control over their drug use; however, participants indicated that OPS were also gendered and racialized spaces that jeopardized some women's access.
CONCLUSION: Although women who use drugs in Vancouver, Canada appear to feel that overdose prevention sites address forms of everyday violence made worse by the overdose epidemic, these sites remain 'masculine spaces' that can jeopardize women's access.
© 2018 Society for the Study of Addiction.

Entities:  

Keywords:  Harm reduction; intersectionality risk environment; overdose; safe consumption sites; violence; women

Mesh:

Year:  2018        PMID: 30211453      PMCID: PMC6400212          DOI: 10.1111/add.14417

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  51 in total

1.  The social structural production of HIV risk among injecting drug users.

Authors:  Tim Rhodes; Merrill Singer; Philippe Bourgois; Samuel R Friedman; Steffanie A Strathdee
Journal:  Soc Sci Med       Date:  2005-03-19       Impact factor: 4.634

2.  Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.

Authors:  Evan Wood; Mark W Tyndall; Julio S Montaner; Thomas Kerr
Journal:  CMAJ       Date:  2006-11-21       Impact factor: 8.262

3.  Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.

Authors:  Brandon D L Marshall; M-J Milloy; Evan Wood; Julio S G Montaner; Thomas Kerr
Journal:  Lancet       Date:  2011-04-15       Impact factor: 79.321

4.  Mapping violence and policing as an environmental-structural barrier to health service and syringe availability among substance-using women in street-level sex work.

Authors:  K Shannon; M Rusch; J Shoveller; D Alexson; K Gibson; M W Tyndall
Journal:  Int J Drug Policy       Date:  2008-01-18

Review 5.  Rapid qualitative research methods during complex health emergencies: A systematic review of the literature.

Authors:  Ginger A Johnson; Cecilia Vindrola-Padros
Journal:  Soc Sci Med       Date:  2017-08-02       Impact factor: 4.634

6.  Women's health and use of crack cocaine in context: structural and 'everyday' violence.

Authors:  Vicky Bungay; Joy L Johnson; Colleen Varcoe; Susan Boyd
Journal:  Int J Drug Policy       Date:  2010-02-08

7.  Survey of drug consumption rooms: service delivery and perceived public health and amenity impact.

Authors:  Jo Kimber; Kate Dolan; Alex Wodak
Journal:  Drug Alcohol Rev       Date:  2005-01

8.  Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study).

Authors:  Jennifer L Evans; Judith A Hahn; Kimberly Page-Shafer; Paula J Lum; Ellen S Stein; Peter J Davidson; Andrew R Moss
Journal:  J Urban Health       Date:  2003-03       Impact factor: 3.671

9.  Rethinking risk: gender and injection drug-related HIV risk among female sex workers and their non-commercial partners along the Mexico-U.S. border.

Authors:  Jennifer L Syvertsen; Angela M Robertson; Steffanie A Strathdee; Gustavo Martinez; M Gudelia Rangel; Karla D Wagner
Journal:  Int J Drug Policy       Date:  2014-02-14

10.  A qualitative study of transgender individuals' experiences in residential addiction treatment settings: stigma and inclusivity.

Authors:  Tara Lyons; Kate Shannon; Leslie Pierre; Will Small; Andrea Krüsi; Thomas Kerr
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-05-07
View more
  40 in total

1.  Characterising the increasing prevalence of crystal methamphetamine use in Vancouver, Canada, from 2006-2017: A gender-based analysis.

Authors:  Paxton Bach; Kanna Hayashi; M-J Milloy; Ekaterina Nosova; Thomas Kerr; Evan Wood; Nadia Fairbairn
Journal:  Drug Alcohol Rev       Date:  2020-07-14

2.  Trusting the source: The potential role of drug dealers in reducing drug-related harms via drug checking.

Authors:  Geoff Bardwell; Jade Boyd; Jaime Arredondo; Ryan McNeil; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2019-03-06       Impact factor: 4.492

3.  Elevated prevalence of self-reported unintentional exposure to fentanyl among women who use drugs in a Canadian setting: A cross-sectional analysis.

Authors:  Sanjana Mitra; Jade Boyd; Evan Wood; Cameron Grant; M-J Milloy; Kora DeBeck; Thomas Kerr; Kanna Hayashi
Journal:  Int J Drug Policy       Date:  2020-07-20

4.  The intersectional risk environment of people who use drugs.

Authors:  Alexandra B Collins; Jade Boyd; Hannah L F Cooper; Ryan McNeil
Journal:  Soc Sci Med       Date:  2019-06-22       Impact factor: 4.634

5.  "Bed Bugs and Beyond": An ethnographic analysis of North America's first women-only supervised drug consumption site.

Authors:  Jade Boyd; Jennifer Lavalley; Sandra Czechaczek; Samara Mayer; Thomas Kerr; Lisa Maher; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2020-04-02

6.  Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites.

Authors:  Alexandra B Collins; Jade Boyd; Samara Mayer; Al Fowler; Mary Clare Kennedy; Ricky N Bluthenthal; Thomas Kerr; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2019-09-18

7.  Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: A gender-based analysis.

Authors:  Mary Clare Kennedy; Kanna Hayashi; M-J Milloy; Jade Boyd; Evan Wood; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2020-03-19

8.  Police-related barriers to harm reduction linked to non-fatal overdose amongst sex workers who use drugs: Results of a community-based cohort in Metro Vancouver, Canada.

Authors:  Shira Goldenberg; Sarah Watt; Melissa Braschel; Kanna Hayashi; Sarah Moreheart; Kate Shannon
Journal:  Int J Drug Policy       Date:  2019-12-12

9.  Women's utilization of housing-based overdose prevention sites in Vancouver, Canada: An ethnographic study.

Authors:  Alexandra B Collins; Jade Boyd; Kanna Hayashi; Hannah L F Cooper; Shira Goldenberg; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2019-12-27

10.  Assisted injection within supervised injection services: Uptake and client characteristics among people who require help injecting in a Canadian setting.

Authors:  Mary Clare Kennedy; M-J Milloy; Kanna Hayashi; Elizabeth Holliday; Evan Wood; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2020-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.